Tactile Medical signs exclusive distribution deal for ElastiMed's MyoSleeve compression device for VA/DoD patients

TACTILE SYSTEMS TECHNOLOGY INC

Exclusive U.S. distribution rights for MyoSleeve within VA and DoD systems.
Upfront payment of $3 million to ElastiMed; minimum purchase obligations and marketing commitments.
MyoSleeve is FDA 510(k)-cleared for chronic swelling, lymphedema, and venous insufficiency.
Device uses electroactive polymer technology, battery-powered, no cords or external controller.
Expands Tactile Medical's portfolio to earlier stages of chronic swelling, complementing existing pneumatic devices.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.